EYA2 and hepatocellular carcinoma: It will be interesting to determine whether there are somatic mutations or deletion at the EYA2 locus in HCC genomes that could result in functional inactivation of the tyrosine phosphatase or changes in binding capacity of transcriptional coactivator.